Literature DB >> 11825045

Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses.

E Vardas1, M H Ross, G Sharp, J McAnerney, J Sim.   

Abstract

The prevalence of hepatitis A, B and C antibodies was measured in a group of healthcare workers (HCWs) at increased risk of occupational acquisition of blood-borne viruses (N=402) from a large, urban referral hospital in South Africa. The aims of this study were to determine the immunity of HCWs to these agents and to recommend policy for the protection of HCWs against occupational exposure to viral hepatitis in this country. Race, sex and age were shown to be important factors influencing the presence of hepatitis A (HAV) antibodies. Most black HCWs (96.2%) are protected from HAV infection. Females have significantly higher HAV antibodies compared with males and antibodies increase with increasing age. Hepatitis B antibodies (anti-HBs) were found in 30.6% of HCWs. Anti-HBs levels were significantly associated with a past history of HBV vaccination. However, only a small proportion of HCWs (21.2%) could remember ever being immunized against HBV. For those individuals that did receive HBV vaccination (N=83), the mean number of years since their last vaccine was 6.2 years (SD +/- 3.5). HCV antibodies were found in 1.8% of HCWs at increased risk of occupational exposure. It was not possible to define whether these infections were occupationally acquired but genotyping of the HCV (in two of seven cases) showed genotype 5, the predominant South African genotype. New recommendations for the prevention of viral hepatitis in HCWs in South Africa are made, including pre-employment screening for HAV based on self-selection criteria, universal anti-HBs screening with HBV booster vaccination. HCV recommendations are based on appropriate education of HCWs about this infection and its prevention and a standardized post-exposure testing protocol. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825045     DOI: 10.1053/jhin.2001.1143

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.

Authors:  Ilanca Fraser; Johanita Burger; Martie Lubbe; George Dranitsaris; Mark Sonderup; Tienie Stander
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

2.  Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China.

Authors:  Wei-Min Ke; Xue-Jun Li; Li-Na Yu; Jing Lai; Xiao-He Li; Zhi-Liang Gao; Pei-Jia Chen
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

Review 3.  The prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysis.

Authors:  Claudia Westermann; Claudia Peters; Birgitte Lisiak; Monica Lamberti; Albert Nienhaus
Journal:  Occup Environ Med       Date:  2015-10-05       Impact factor: 4.402

4.  Hepatitis B vaccination coverage amongst healthcare workers in a tertiary academic hospital in Gauteng province, South Africa.

Authors:  Lufuno L Razwiedani; Ntlogeleng M Mogale; Muthuhadini P B Mawela
Journal:  S Afr J Infect Dis       Date:  2022-07-27

5.  Seroprevalence of hepatitis B virus among health care workers in Korea.

Authors:  Bo-Moon Shin; Hyeon Mi Yoo; Ae Sook Lee; Sang Keun Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

6.  Hepatitis B and C virus infection among healthcare workers in Africa: a systematic review and meta-analysis.

Authors:  Daniel Atlaw; Biniyam Sahiledengle; Zerihun Tariku
Journal:  Environ Health Prev Med       Date:  2021-06-02       Impact factor: 3.674

7.  Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran.

Authors:  Masomeh Bayani; Mahmoud Sadeghi; Narges Kalantari; Abdolah Sayadmanesh
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

8.  Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why?

Authors:  Dotto Aaron; Tumaini J Nagu; John Rwegasha; Ewaldo Komba
Journal:  BMC Infect Dis       Date:  2017-12-20       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.